SGSM2
Basic information
Region (hg38): 17:2337498-2381058
Previous symbols: [ "RUTBC1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SGSM2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 69 | 71 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 69 | 0 | 4 |
Variants in SGSM2
This is a list of pathogenic ClinVar variants found in the SGSM2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
17-2337693-G-T | not specified | Uncertain significance (Apr 01, 2024) | ||
17-2337704-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
17-2337715-A-C | not specified | Uncertain significance (Jan 10, 2023) | ||
17-2343560-G-A | not specified | Uncertain significance (Oct 13, 2023) | ||
17-2361678-G-A | not specified | Uncertain significance (Mar 23, 2022) | ||
17-2361679-C-T | not specified | Uncertain significance (Aug 16, 2022) | ||
17-2361693-C-T | not specified | Uncertain significance (Feb 13, 2023) | ||
17-2361694-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
17-2361711-G-A | not specified | Uncertain significance (May 18, 2023) | ||
17-2361739-G-C | Benign (Dec 28, 2017) | |||
17-2361742-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
17-2361769-T-C | not specified | Uncertain significance (Jan 03, 2024) | ||
17-2362114-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
17-2362129-A-C | not specified | Uncertain significance (Sep 14, 2022) | ||
17-2362242-G-T | not specified | Uncertain significance (Jul 19, 2023) | ||
17-2362851-A-G | not specified | Uncertain significance (Apr 27, 2024) | ||
17-2363025-C-G | not specified | Uncertain significance (May 08, 2023) | ||
17-2363048-C-T | not specified | Uncertain significance (Nov 27, 2023) | ||
17-2363073-G-A | not specified | Uncertain significance (Feb 23, 2023) | ||
17-2363120-C-T | not specified | Uncertain significance (Jan 20, 2023) | ||
17-2363485-C-G | not specified | Uncertain significance (Jun 07, 2023) | ||
17-2363519-G-A | not specified | Uncertain significance (Apr 12, 2024) | ||
17-2363522-C-T | not specified | Uncertain significance (Jan 10, 2023) | ||
17-2363556-G-A | not specified | Uncertain significance (Dec 14, 2023) | ||
17-2363562-G-A | not specified | Uncertain significance (May 09, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SGSM2 | protein_coding | protein_coding | ENST00000268989 | 24 | 43561 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
4.29e-9 | 1.00 | 125665 | 0 | 83 | 125748 | 0.000330 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.299 | 649 | 671 | 0.967 | 0.0000441 | 6840 |
Missense in Polyphen | 149 | 195.88 | 0.76066 | 1973 | ||
Synonymous | -1.49 | 316 | 284 | 1.11 | 0.0000202 | 2039 |
Loss of Function | 3.95 | 24 | 55.9 | 0.430 | 0.00000265 | 633 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000594 | 0.000594 |
Ashkenazi Jewish | 0.0000996 | 0.0000992 |
East Asian | 0.000498 | 0.000489 |
Finnish | 0.000294 | 0.000277 |
European (Non-Finnish) | 0.000321 | 0.000308 |
Middle Eastern | 0.000498 | 0.000489 |
South Asian | 0.000431 | 0.000425 |
Other | 0.000188 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Possesses GTPase activator activity towards RAB32, RAB33B and RAB38 (PubMed:26620560, PubMed:21808068). Regulates the trafficking of melanogenic enzymes TYR, TYRP1 and DCT/TYRP2 to melanosomes in melanocytes by inactivating RAB32 and RAB38. Inhibits RAB32 and RAB38 activation both directly by promoting their GTPase activity and indirectly by disrupting the RAB9A-HPS4 interaction which is required for RAB32/38 activation (PubMed:26620560). {ECO:0000269|PubMed:21808068, ECO:0000269|PubMed:26620560}.;
Recessive Scores
- pRec
- 0.0990
Intolerance Scores
- loftool
- 0.760
- rvis_EVS
- -0.74
- rvis_percentile_EVS
- 13.8
Haploinsufficiency Scores
- pHI
- 0.257
- hipred
- N
- hipred_score
- 0.414
- ghis
- 0.554
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.792
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Sgsm2
- Phenotype
Gene ontology
- Biological process
- intracellular protein transport;late endosome to Golgi transport;positive regulation of GTPase activity;activation of GTPase activity
- Cellular component
- cytoplasm;melanosome
- Molecular function
- GTPase activator activity;Rab GTPase binding